Sale!

Buy 5 mg Dolophine oral tablet online

$48.05

QuantityPer unitPrice
100$0.49$49.05

DOLOPHINE tablets contain either 5 mg or 10 mg of methadone hydrochloride USP for oral use. The inactive ingredients in each tablet are magnesium stearate, microcrystalline cellulose, and pregelatinized starch. Buy 5 mg Dolophine oral tablet online

What is Dolophine 5 MG Oral Tablet

Dolophine 5 MG Oral Tablet is a prescription opioid. A narcotic is a term used to describe an opioid. Dolophine 5 MG Oral Tablet also lowers withdrawal symptoms in heroin or other narcotic drug addicts without creating the “high” associated with drug addiction.
Dolophine 5 MG Oral Tablet is a pain reliever that is also utilised as part of drug addiction detox and maintenance regimens.
Only a certified pharmacy can provide Dolophine 5 MG Oral Tablet.
Dolophine 5 MG Oral Tablet can be used for a variety of other things not included in the Dolophine 5 MG Oral Tablet guide.

Dolophine 5 MG Oral Tablet side effects

If you have any of the following symptoms of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or neck, get immediate medical attention.
Even if you’ve used other narcotic medications, Dolophine 5 MG Oral Tablet could have dangerous side effects.
If you have weak or shallow breathing, severe constipation, a light-headed feeling like you’re about to pass out, or indications of a life-threatening cardiac rhythm disorder, such as a headache with chest pain and severe dizziness, or fast or pounding heartbeats, call your doctor right once.

Common side effects may include:

  • dizziness, drowsiness;
  • nausea, vomiting; or
  • increased sweating.

Usual Adult Dose for Pain:

Oral: Start with 2.5 mg and increase to 10 mg every 8 to 12 hours. The dose can be gradually increased until the desired effect is achieved. More frequent dosing may be required to maintain appropriate analgesia; however, due to methadone’s lengthy elimination half-life, extra vigilance is essential to avoid overdosage.
Starting dose 2.5 mg to 10 mg every 8 to 12 hours via IV, IM, or subcutaneously. The dose can be gradually increased until the desired effect is achieved. More frequent dosing may be required to maintain appropriate analgesia; however, due to methadone’s lengthy elimination half-life, extra vigilance is essential to avoid overdosage.

Usual Adult Dose for Opiate Withdrawal:

15 to 40 mg once a day as a starting dose. Unless the patient is unable to take oral Dolophine 5 MG Oral Tablet, parenteral Dolophine 5 MG Oral Tablet can be administered. If the symptoms of abstinence are severe, further dosages of 5 to 10 mg may be administered.
A 20% daily dose reduction can usually be tolerated after one or two days. Detoxification normally takes 10 days to complete.
Maintenance of opioid addiction: 20–120 mg per day.
Diskets – Oral:
Initial Dosing/Induction:
When there are no evidence of sedation or intoxication and the patient exhibits withdrawal symptoms, the initial Dolophine 5 MG Oral Tablet dose should be given under observation.
Dolophine 5 mg is given in a single dose of 20 to 30 mg.

If same-day dose modifications are needed, the patient should be advised to wait two to four hours after peak levels have been reached for further evaluation. If withdrawal symptoms have not been controlled or if symptoms resurface, an additional 5 to 10 mg of Dolophine 5 MG Oral Tablet may be given. On the first day of treatment, the total daily dose of Dolophine 5 MG Oral Tablet should not exceed 40 mg. During the first week of treatment, dose modifications should be made based on the control of withdrawal symptoms at the time of projected peak activity. Dose adjustments should be made with caution; deaths have occurred in early treatment as a result of the cumulative effects of the first few days of treatment.

Patients whose tolerance is considered to be low at the start of treatment should get lower initial dosages. Any patient who hasn’t used opioids in more than five days should be evaluated for loss of tolerance. Previous treatment sessions or dollars spent each day on illegal drug usage should not be used to calculate initial doses.
For short-term detoxification, it is generally recommended that the patient be titrated to a total daily dose of roughly 40 mg in divided doses to establish an appropriate stabilising level for patients who desire a shorter course of stabilisation followed by a period of medically supervised withdrawal. After 2 to 3 days of stabilisation, the dose of Dolophine 5 MG Oral Tablet should be gradually reduced.

The dose of Dolophine 5 MG Oral Tablet can be reduced on a daily or two-day basis, but the amount consumed must be sufficient to maintain withdrawal symptoms acceptable. A daily reduction of 20% of the total daily dose may be tolerated in hospitalised patients. A slightly slower timetable may be required in ambulatory patients. Diskets may not be the best product for gradual dose reduction in many people because they can only be given in 10 mg increments.
Treatment for routine maintenance:

Patients in maintenance treatment should be titrated to a dose that prevents opioid symptoms for 24 hours, reduces drug hunger or seeking, blocks or attenuates the euphoric effects of self-administered opioids, and the patient is tolerant of Dolophine 5 MG Oral Tablet’s sedative effects. Clinical stability is usually achieved at dosages of 80 to 120 mg per day.
In patients who choose medically supervised withdrawal from Dolophine 5 MG Oral Tablet treatment after a period of maintenance treatment, there is considerable diversity in the optimum rate of Dolophine 5 MG Oral Tablet taper.

Dose reductions should be less than 10% of the established tolerance or maintenance dose, with 10 to 14 day intervals between dose decreases. Diskets may not be the best product for gradual dose reduction in many people because they can only be given in 10 mg increments. Patients should be informed about the significant risk of relapse to illegal drug use when Dolophine 5 MG Oral Tablet maintenance treatment is stopped.

Usual Pediatric Dose for Pain:

Note: Doses should be titrated to appropriate effects:
Neonatal abstinence syndrome:
Oral or IV:
Initial: 0.05 to 0.2 mg/kg/dose given every 12 to 24 hours or 0.5 mg/kg/day divided every 8 hours. Individualize dose and tapering schedule to control symptoms of withdrawal. Usually taper dose by 10 to 20% per week over 1 to 1 and 1/2 months. Note: Due to long elimination half-life, tapering is difficult; consider alternate agent.
Note: Doses should be titrated to appropriate effects:
Children:
Analgesia: Note: Dosing interval may range from 4 to 12 hours during initial therapy. Decrease in dose or frequency may be required approximately 2 to 5 days after initiation of therapy or dosage increase due to accumulation with repeated doses.
IV:
Initial: 0.1 mg/kg/dose every 4 hours for 2 to 3 doses, then every 6 to 12 hours as needed
Maximum dose: 10 mg/dose
Oral, IM, SubQ:
Initial: 0.1 mg/kg/dose every 4 hours for 2 to 3 doses, then every 6 to 12 hours as needed or 0.7 mg/kg/24 hours divided every 4 to 6 hours as needed
Maximum dose: 10 mg/dose
Iatrogenic narcotic dependency:

Oral:
Controlled studies have not been conducted. Several clinically used dosing regimens have been reported. Dolophine 5 MG Oral Tablet dose must be individualized and will depend upon the previous narcotic dose and severity of opioid withdrawal. Patients who have received higher doses of narcotics will require higher Dolophine 5 MG Oral Tablet doses.
General guidelines:
Initial: 0.05 to 0.1 mg/kg/dose every 6 hours
Increase by 0.05 mg/kg/dose until withdrawal symptoms are controlled. After 24 to 48 hours, the dosing interval can be lengthened to every 12 to 24 hours. To taper dose, wean by 0.05 mg/kg/day. If withdrawal symptoms recur, taper at a slower rate.

 

Category:

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.